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ABSTRACT
To determine whether a minimum number of assembled microtubules is required
for very low density lipoprotein (VLDL) triglyceride (TG) secretion in hepato-
cytes, antimicrotubule drugs ofdifferent concentrations were given to rats . Hepatic
VLDL-TG release was subsequently measured by a liver perfusion system, and
hepatocyte ultrastructural changes were analyzed by quantitative ultrastructural
methods . The results demonstrate a tight coupling between the reduction in
hepatocyte microtubule content and the reduction in hepatic VLDL-TG secretion
which is related to the dose of colchicine or vinblastine administered . The various
estimates imply that a minimum number of microtubules is necessary for hepatic
VLDL secretion to proceed normally and that hepatic VLDL secretion rates reach
their nadir (10-30% of control) when microtubules comprise <0.005% of the
cytoplasm (or <I0% of control values) . At this point, hepatocyte Golgi complexes
are also greatly altered ; Golgi complexes with recognizable dictyosomal mem-
branes are reduced to 15% of control values and the region is filled with large
numbers of electron-dense bodies which appear to be lysosomes in the process of
digesting VLDL . There is a predilection for the remaining Golgi complexes to be
associated with a few segments of microtubules, even when no microtubules can
be measured in random samplings of hepatocytes . Clusters of vacuoles containing
VLDL are also present throughout the cytoplasm; the limiting membranes of25%
of these vacuoles are studded with ribosomes . These findings demonstrate that the
administration of antimicrotubule agents results in decreases in hepatic VLDL-
TG secretion which are associated with loss of microtubules and alteration of
existing Golgi complexes .
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Hepatocytes synthesize and secrete triglycerides
primarily in the form of very low density lipopro-
teins (VLDL) . Recent studies from our laboratory
(14) demonstrated that both acute and sustained
increases in VLDL secretion can occur without
measurable changes in the hepatocyte content of
either the assembled or disassembled form of mi-
crotubule protein . This observation raised certain
issues concerning the role of microtubules in
VLDL secretion, and led to the present study in
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28-39which three questions were considered . One, can
VLDL secretion occur in the absence ofassembled
microtubules? Two, is there a minimum number
of assembled microtubules required for VLDL
secretion? Three, when microtubules are absent,
what structural changes, if any, occur in hepato-
cytes? To help answer these questions, antimicro-
tubule drugs ofdifferent concentrations were given
to rats . After various periods of time, hepatic
VLDL release was measured in a liver perfusion
system, and hepatocytes were examined for ultra-
structural changes .
MATERIALS AND METHODS
Animal Protocol
Young (250-350 g) male Sprague-Dawley rats were used for
all studies . The rats were fed standard laboratory chow (Wayne
Lab Blox, Allied Mills, Inc., Chicago, Ill .) and were maintained
on a l2-h light and dark (6 a.m./6 p.m .) cycle . On the morning
of an experiment, food was removed from the animals, and I h
later the rats were injected with saline or freshly prepared col-
chicine (Sigma Chemical Co ., St . Louis, Mo.) (0.05-2 .5 mg/kg
body weight), vinblastine sulfate (gift from R . M . Hosley, Eli
Lilly and Co., Indianapolis, Ind.) (0.5-5 .0 mg/kg body weight),
or lumicolchicine (prepared as described by Mizel and Wilson
[71) (2 .5 mg/kg body weight). In general, two animals were
studied each day : one rat was injected with either colchicine,
vinblastine, or lumicolchicine, while the second rat was injected
with saline . 3 h later the rats were anesthetized with sodium
thiamylal (40-50 mg/kg), and the liverswere perfused in situ (by
methods previously described in detail 1141) with oleic acid (0.7-
0.8 mEq/Liter) as an exogenous substrate source for VLDL-
triglyceride (TG) synthesis . Timed samples of perfusate were
removed over a 2-h period, and TG concentrations were meas-
ured (1). VLDL-TG secretion rates were calculated from knowl-
edge ofthese data and the perfusate volume .
Immediately after the 2-h perfusion, each liver was briefly
flushed with a cacodylate/sucrose buffer (7% sucrose in 0.1 M
cacodylate; 22°C ; pH 7.2; 350 mosmol) and perfused for 5 min
with 2% glutaraldehyde in 0.1 M cacodylate buffer (22°C ; pH
7.2 ; 420 mosmol) . Liver samples from the left lobe were minced
and submerged in the fixative for three additional hours at 22°C .
Thereafter, the tissue samples were washed two times with the
sucrose/cacodylate buffer, and left in _buffer overnight at 4°C.
Further processing of the tissue was continued the next day .
Ultrastructural Morphometric Methods
GENERAL PROCEDURE :
￿
Fixed and washed tissue samples
were subsequently postfixed for 1 h in 1% osmium tetroxide
(veronal buffer; pH 7 .2 ; 22 °C) and stained en bloc for 45 min
(2% uranyl acetate in veronal buffer, pH 5 .5 ; 22 °C) before
dehydration in graded alcohols and embedment in Epon-Araldite
plastic . Thick sections which revealed portal areas were subse-
quently thin sectioned (400-500 A), stained with uranyl acetate
and lead citrate, and viewed with a JEM-100 B (Jeol Co .,
Burlingame, Calif) electron microscope .
ASSESSMENT OF MICROTUBULE CONTENT IN
HEPATOCYTES : These procedures have been described in de-
tail in previous publications (1l, 12, 14) . In brief, six nucleated
hepatocytes chosen at random from one block of each rat liver
were photographed in the 12 o'clock and 6 o'clock positions at
x 16,000. Care was taken to include the nuclear membrane in
one picture and the plasma membrane in the second picture of
each cell . These electron micrographs were photographically
enlarged to x 48,000. All microtubule lengths and cross sections
were identified on the prints, and microtubule volume density
relative to cytoplasmic volume density was estimated by point-
counting stereological techniques (l9).
CONTENT OF VARIOUS CYTOPLASMIC ORGANELLES IN
HEPATOCYTEs : Each hepatocyte photographed for the study
of microtubules was also photographed at x 3,000 (to include
the profile of the entire cell) and at x 8,000 . The lowest magni-
fication photographs were used to assess changes in the distri-
bution of various organelles ; higher magnification photographs
were used to estimate the content ofGolgi complexes and lyso-
somes, and the distribution of hepatocyte VLDL. For these
purposes, Golgi complexes were considered to be "intact" when
at least one dictyosome cisterna was found associated with coated
and smooth vesicles and/or VLDL-containing vacuoles. Lyso-
somes were identified as electron-dense bodies containing frag-
ments ofcellular structures in various stages ofdigestion. VLDL
were separately quantitated in: (a) Golgi vacuoles associatedwith
Golgi complexes; (b) smooth (SER) or rough-surfaced endoplas-
mic reticulum (RER); and (c) lysosomes .
ASSESSMENT OF MICROTUBULE ASSOCIATIONS :
￿
POSIfiX-
ation microtubule association with other structures of the cell
was evaluated by a modified version of the "random circle"
morphometric method developed in this laboratory (13) . This
method is based on the premise that microtubule cross sections
are clearly identifiable at the magnification used (x 48,000), and
that one can quantify the proximity of these cross sections to
various organelles on micrographs and compare the value with
one obtainedbyquantifying the centers ofrandom circles (drawn
by a computer) on the same pictures.` In the present study we
assessed the proximityofmicrotubule cross sections to thefollow-
ing three secretory organelles : Golgi complexes, VLDL-contain-
ing vacuoles (not associated with Golgi complexes), and plasma
membranes .
The total number of microtubules associated with the Golgi
complex was analyzed by an independent method as follows :
Golgi areaswere sought in otherwise randomly selected cells and
photographed at x 16,000 . Intact Golgi regions (Golgi cisternae
and associated vesicles and/or VLDL-containing vacuoles) were
identified on threefold magnified photographic prints of the
original micrographs, and their general outlines were encircled
with a pencil . A second line, separated from the first by I cm,'
' Cross sections of microtubule were used exclusively in
this study to eliminate arbitrary decisions as to which
part of a microtubule longitudinal segment one should
use in the analysis (e .g ., the center or either end point) .
Although it is possible that some microtubule cross
sections are not correctly identified in photographs of
hepatocytes, errors in identification occur without bias,
i.e ., microtubule cross sections near Golgi membranes
have as much opportunity to be correctly or incorrectly
identified as microtubule cross sections near plasma
membranes . As a result, we believe that no systematic
error is introduced into the analysis .
z This distance was arbitrarily chosen after inspection of
numerous prints of Golgi regions; at x 48,000, many
microtubules, which seem to relate to Golgi areas, are
not actually within the complexes but close to them .
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29was then drawn following the contours of the first line. All
microtubule lengths or cross sections found within the area
enclosed by the second line were considered to be associated with
the Golgi complex; all other microtubule segments within the
micrographs were considered not associated with the Golgi com-
plex . Each microtubule segment, regardless of length, received
one count unless it traversed both regions, in which case it was
counted in each region. Subsequently, the total area enclosed by
the Golgi regions (plus the additional 1 cm) and non-Golgi
cytoplasmic regions was estimated so that the number ofmicro-
tubules observed in each region could be assessed per unit area.
RESULTS
Effect ofAntimicrotubule Agents on VLDL-
TG Secretion Rates
COLCHICINE : Fig. 1 indicates that VLDL-
TG secretion from perfused livers of control (sa-
line) rats is 2.3 mg/h per gram liver. Hepatic
VLDL-TG secretion rates do not decrease 3-5 h
after the administration of 0.15 mg colchicine/kg
body weight, but colchicine in a dose of 0.3 mg/
kg leads to a fall in mean VLDL-TG secretion
rate to 70% of the control values (P< 0.01) . At a
colchicine dose of0.5 mg/kg, VLDL-TG secretion
rates fall to -30% of control values (P < 0.01) .
Further increases in the amount of administered
colchicine lead to only relatively small decrements
in the absolute hepatic VLDL-TG secretion rate .
The use of lumicolchicine at a dose equivalent to
the highest colchicine dose (2.5 mg/kg) does not
alter VLDL-TG secretion rates .
VINBLASTINE SULFATE : Like colchicine,
vinblastine administration also leads to a dose-
related depression ofVLDL-TG secretion; in this
instance, 0.5 and 1 mg vinblastine/kg do not affect
TG secretion ; 2.5 mg/kg vinblastine reduces TG
secretion to 70% of control values, and 5 .0 mg
vinblastine/kg reduces TG secretion to 30% of
control values .
Effect ofAntimicrotubule Agents on
Hepatocyte Microtubule Content
COLCHICINE : Fig . 2 shows hepatocyte mi-
crotubule volume density at the end of the perfu-
sion experiments (or 5 h after the injection of
either saline, colchicine, or vinblastine) . When no
colchicine is given (saline), microtubule volume
density is -0.03% of the cytoplasm . This value
does not change significantly until colchicine is
given to rats at a . dose of 0.3 mg/kg ; at this point
there is a striking fall in microtubule volume den-
sity to -15% of control values . Hepatocyte micro-
tubule content decreases almost to zero at a dose
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of 0.5 mg colchicine/kg. A fivefold increase in
administered colchicine leads to a further small
reduction in microtubule volume density . Lumi-
colchicine, on the other hand, does not alter nor-
mal hepatocyte microtubule volume density, even
when administered at a dose of 2.5 mg/kg body
weight . Since tissues were obtained at the end of
the perfusion period (5 h after colchicine), it was
of interest to determinethemicrotubule content of
cells 3 h after colchicine treatment (a stage just
before the start of perfusion) . These studies were
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FIGURE 1
￿
HepaticVLDL-TG secretion rates observed
after increasing doses of colchicine. Data are expressed
as mean (t SEM) secretion rates 3-5 h after the admin-
istration of saline (clear bar), colchicine (hatched bars),
or lumicolchicine (stippled bar) . Figures in parentheses
represent the number of livers perfused at each drug
dose .
FIGURE 2 Hepatocyte microtubule content 5 h after
the administration of various doses of colchicine . Data
are expressed as mean (t SEM) volume density of
microtubules . The key is the same as in Fig . l . Figures
in parentheses represent the number of rats from which
tissue was analyzed at each given dose ofcolchicine .performed with an administered colchicine dose
of 0.7 mg/kg, andthe results of six studies indicate
that there is no difference in the microtubule
content at 3 and at 5 h after the administration of
this dose of colchicine .
VINBLASTINESULFATE :
￿
Theadministration
of vinblastine results in a similar decline in hepa-
tocyte microtubule content . When given to three
rats at 1 mg/kg, vinblastine has no effect on
hepatocyte microtubule content (mean ± SEM
volume density of microtubules is 0.030 ± 0.001 ;
at 2.5 mg/kg (n = 3), the content of microtubules
drops to 50% of control values, and at 5.0 mg/kg
(n = 3), no microtubules can be found in hepato-
cytes .
Relationship between Changes in VLDL-TG
Secretion and Microtubule Volume Density
Fig . 3 directly compares the effect of colchicine
on VLDL-TG secretion (Fig . 1) and hepatocyte
microtubule content (Fig . 2), and several points
can be made from these data . First, there is re-
markable similarity in the shape of the two dose-
response curves : the range of colchicine in which
the most dramatic changes occur in both variables
is very small (between 0.15 and 0.5 mg colchicine/
kg) . Second, despite the general parallelism be-
tween the two curves, dissociation betweenVLDL
secretion and microtubule content can be demon-
strated after the administration of 0.3 mg colchi-
cine/kg : 5 h after this dose of colchicine, a much
greater reduction in microtubule volume density
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FIGURE 3
￿
Comparison of hepaticVLDL-TG secretory
response and hepatocyte microtubule response to in-
creasing doses of administered colchicine . Data are de-
rived from Figs . l and 2, and are plotted as percent of
the control (saline) value . Triangles represent mean (±
SEM) secretory rates; circles represent values for mean
(± SEM) microtubule content.
(85%) is seen than in VLDL-TG secretion (30%) .
Finally, Fig. 3 shows that hepatic VLDL-TG se-
cretion can continue at a low level (10-30% of
control values) at a point (i .e ., after a colchicine
dose of 0.5-2.5 mg/kg) when microtubules are
largely absent in cells analyzed by random sam-
pling techniques .
Although the data are not so complete, a similar
relationship exists between the dose of adminis-
tered vinblastine and the VLDL-TG secretionand
microtubule content, i.e., VLDL-TG secretion is
shown to be significantly (P < 0.01) reduced at
concentrations of vinblastine that depress micro-
tubule content by 50% . However, as with colchi-
cine, VLDL-TG secretion can continue at 30% of
control values at a time when microtubule volume
density has been reduced almost to zero .
Effect ofAntimicrotubule Agents on the
Content of Various Cytoplasmic Organelles
When VLDL-TG secretion and microtubule
content are reduced after the administration of
colchicine (0.3-2.5 mg/kg) or vinblastine (2.5-5.0
mg/kg), distinct morphological changes appear in
hepatocytes. First, vacuoles filled with VLDL ap-
pear isolated or in clusters within the cytoplasm
(Fig . 4) . Although the membranes of many of
these vacuoles are associated with ribosomes(Figs .
4 and 5), and appear to be engorged portions of
the RER, the majority of the vacuole membranes
are smooth surfaced (Figs . 4 and 6) .
In addition, variable numbers of lysosomes are
seen throughout the cytoplasm (Fig. 4) . These
electron-dense bodies frequently containremnants
ofVLDL which, except for their unusual density,
resemble the VLDL-filled vacuoles often associ-
ated with Golgi complexes (Fig . 4). Golgi com-
plexes in general appear altered after colchicine
treatment . The most apparent change is the large
number of lysosomes associated with Golgi com-
ponents (Figs . 7-9) . On closer inspection, it is clear
that stacked cisternal membranes are reduced in
amount in Golgi regions . Indeed, in cells of ani-
mals treated with relatively high doses of colchi-
cine (>0.7 mg/kg), it is rare to come upon an
"intact" Golgi complex (that is, a region in which
stacked cisternal membranes are associated with
VLDL-filled vacuoles and small coated and
smooth vesicles) .
In an effort to quantitate the observed changes
in Golgi complexes, lysosomes(dense bodies), and
accumulation of VLDL, various morphometric
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￿
Low magnification view of representative portion of hepatocyte cytoplasm from rat injected
with colchicine (0 .7 mg/kg) 4 h earlier . Cytoplasm shows normal arrangement of RER, SER, and
mitochondria, but striking increase in number of lysosomes (L) and vacuoles filled with VLDL (V) . x
35,000 .
32FIGURE 5
￿
Single VLDL-filled vacuole surrounded by membrane-containing ribosomes . Vacuoles of this
type are found in rats treated with colchicine (0.3-1 .0 mg/kg) . x 60,000. Inset shows higher magnification
view of the same vacuole membrane . x 100,000 .
FIGURE 6
￿
Representative cluster of smooth-surfaced vacuoles containing VLDL. This group was from
same cell as rough-surfaced vacuole in Fig. 5 . x 60,000.
measurements were made on hepatocytes of ani-
mals given colchicine . Golgi complexes were eval-
uated in cells of rats given several different doses
of colchicine previously shown to reduce hepatic
VLDL-TG secretion and hepatocyte microtubule
content (Figs. 1-3). Lysosomes and VLDL-con-
taining organelles were evaluated in hepatocytes
of animals given 0 .3 mg/kg colchicine, which re-
sults in moderate reduction of VLDL secretion,
and 0 .7 mg/kg colchicine, which results in near
maximal reduction ofVLDL secretion (Figs . 1 and
3) . These results appear in Table I and make the
following points : First, intact Golgi complexes
comprise slightly more than 2% of normal hepa-
tocyte cytoplasm . When colchicine is given in a
dose of 0.3-0.5 mg/kg, the mean volume of Golgi
complexes is not statistically different from that of
control animals. However, when colchicine is
given in a higher dose (0.7-1 .0 mg/kg), hepato-
cytes lose 85% of their normal content of intact
Golgi complexes . Although not shown in Table I,
the colchicine-induced reduction in Golgi com-
plexes is not selective for special regions of the
cells, i.e ., after 0.7 mg/kg colchicine, 35% of the
remaining intact Golgi complexes are still associ-
ated with bile canaliculi as they are in untreated
cells . Table I indicates also that hepatocyte VLDL
compartmentalization is altered after animals are
treated with both 0.3 and 0.7 mg/kg colchicine . In
hepatocytes of saline-treated rats, the vast majority
of VLDL are associated with Golgi vacuoles
within the Golgi compartment . After 0 .3 mg col-
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uoles in the Golgicompartment is not significantly
changed, but increasing amounts of VLDL are
associated with lysosomes (Fig. 7) and endoplas-
mic reticulum . After 0.7 mg/kg colchicine, few
intact Golgi remain . As a result, fewer VLDL
overall are associated with Golgi complexes (Fig .
8) . However, the content of VLDL within lyso-
somes and within endoplasmic reticulum is in-
creased sevenfold.
Although not shown in Table 1, it was found
that in cells of saline-treated rats, 95% of the
VLDL (not associated with Golgi complexes) are
found in SER and only 5% in RER; in cells of
colchicine-treated rats (0 .7 mg/kg), this ratio
changes andonly 74% of the non-GolgiVLDL are
found in SER, whereas 26% are in RER.3 Also,
FIGURE 7
￿
An intact Golgi region of hepatocyte of colchicine-treated (03 mg/kg) rat. The region shows
well-developed dictyosomal cisternae (C) and numerus small vesicles of both the smooth and the coated
variety . Several vacuoles (V) contain VLDL, and some appear to be lysosomes (L) containing remnants
of VLDL . A microtubule cross section is encircled ; microtubule length is indicated by arrowhead . x
60,000.
"Although images in Figs . 4 and 5 suggest that the
membranes ofVLDL-filled vacuoles contain ribosomes,
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VLDL tends to accumulate in extracellular sites
(Fig. 9) in colchicine-treated livers, e.g ., in livers
ofrats given 0.5-1 .0mg/kgcolchicine, the amount
ofVLDL found between hepatocytes is 5- to 10-
fold that found in livers of saline-treated animals.
These morphological effects of colchicine on
hepatocytes are seen also after treatment with
vinblastine sulfate . After 5.0 vinblastine/kg, Golgi
complexes are reduced by 85% (±10%) . Although
not specifically measured, the content and distri-
bution of lysosomes and of VLDL in various
cellular compartments after administration of 5.0
mg of vinblastine/kg, appear identical to those
seen after treatment with 0.7 mg/kg colchicine .
it is not always possible (at magnifications convenient
for morphometric measurements) to distinguish between
a vacuole of this sort and a smooth-surfaced vacuole
with a closely applied segment of RER. As a result, the
estimate for VLDL in RER membranes may be some-
what inflated .FIGURE 8
￿
Golgi region from colchicine-treated (0 .7 mg/kg) rat . Golgi cisternae (C) are still apparent in
this micrograph (though greatly reduced overall; see Table 1) . The region contains a great increase in
lysosomes (L) (many ofwhich include VLDL remnants) and a variety ofsmall smooth and coated vesicles .
x 60,000 .
Association ofMicrotubules with Various
Organelles of the Cell
When analyzed by the "random circle" method,
microtubules in untreated hepatocytes are found
to have a special, statistically significant relation-
ship to Golgi complexes (P < 0.01), but not to
certain other structures (such as lysosomes,VLDL-
filled vacuoles, and plasma membrane) thought to
be involved in hepatocyte VLDL disposal . When
this distribution of microtubules is estimated per
unit volume of cytosplasm, it appears that 78% of
all microtubules (found in micrographs of Golgi
regions of cells of control animals) are closely
associated with Golgi complexes . In contrast, there
are far fewer Golgi complexes in cells of rats
treated with 0.7 mg colchicine/kg (see Table I),
and very few microtubules overall (see Fig . 2) . Of
the remaining microtubules, however, >95% are
associated with the remaining Golgi complexes
(see Figs. 7 and 9), suggesting a unique, spatial
relationship between these structures even after
colchicine treatment .
DISCUSSION
These studies demonstrate that the disruption of
hepatocyte microtubules that follows the admin-
istration of either colchicine or vinblastine is as-
sociated with a reduction in hepatic VLDL-TG
secretion. The most dramatic effects occur over a
very small range of administered drug, i.e ., be-
tween 0.15 mg colchicine/kg (where no changes
are seen in either VLDL-TG secretion or micro-
tubule content) and 0 .5 mg colchicine/kg (where
near-maximal changes are seen in both TG secre-
tion and microtubule content). Furthermore, there
appears to be a striking degree of parallelism
between the effect of antimicrotubule agents on
hepatocyte microtubule content and the effect on
hepatic VLDL-TG secretion (see Fig. 3) . The ap-
parent existence of such an exceedingly tight cou-
pling between hepatocyte microtubule content and
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relationship between thetwo, and the fact that this
is observed after the use of two totally different
antimicrotubuleagents (colchicine and vinblastine
sulfate) adds support for this view . The precise
nature of the relationship between hepatocyte mi-
crotubule content and hepatic VLDL-TG secre-
tion remains to be defined, but the results pre-
sented indicate that near-normal (70% of control)
hepaticVLDL-TG secretion canbe maintained in
spite of a fall in hepatocyte microtubule volume
to 15% of control values (see Fig . 3). On the other
hand, a further fall of only 5% in hepatocyte
microtubule content (to a total of a 90%reduction)
leads to a dramatic and near-maximal fall in
VLDL-TG secretion . These data suggest that mi-
crotubules must comprise at least 0.005% of the
cytoplasm to sustain hepatic VLDL-TG secretion .
FIGURE 9 Golgi region from colchicine-treated (0.5 mg/kg) rat . Dictyosomal cisternae (C) are still
present in this micrograph . The region contains a variety of small vesicles and a few lysosomes (L)
containing remnants ofVLDL . A microtubule cross section is encircled . This photograph also shows the
abnormal accumulation of VLDL (arrowheads) between hepatocytes (typically in an enclosed space
adjacent to a bile canaliculus but bounded by desmosomes). x 60,000 .
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Although we have emphasized the tightly cou-
pled nature of the fall in hepatocyte microtubule
content and in hepatic VLDL-TG secretion that
occurs when several different doses of colchicine
and vinblastine are given, these data also demon-
strate a dissociation in the response of these two
variables to a critical level of colchicine . Thus, a
dose of 0.3 mg/kg of colchicine results in an 85%
fall in microtubule content and only a 30% fall in
VLDL-TG secretion . This difference is statistically
significant (P < 0.01) . In keeping with the idea
that VLDL-TG secretion may be functionally re-
lated to microtubule content, one could interpret
this observation to mean that microtubules are
disrupted in advance of the deterioration of
VLDL-TG secretion.
The disorganization of Golgi complexes ob-
served in hepatocytes after colchicine treatmentmay also be related to the loss of microtubules. 5
h after treatment of rats with 0.15 or 0.30 mg of
colchicine/kg, the content and distribution of
Golgi complexes appear quite normal. After 0.5
mg colchicine/kg, when microtubules are reduced
to <10% of the control value, Golgi complexes
show a small, yet statistically insignificant, fall in
content. However, thecontent ofintact Golgicom-
plexes is reduced to 10% of the control value (P
< 0.01) after the administration of 0.7 mg of
colchicine/kg. At this point the remaining intact
Golgi complexes are often associated with a few
segments of microtubules, although microtubules
areso generallyscarce in hepatocytes from animals
given this dose of colchicine that they cannot be
measured at all in random cell samplings. When
specifically quantitated, >95% of the few micro-
tubules remaining in cells at this stage are closely
associated with Golgi complexes. These observa-
tionssuggesta special relationship between micro-
tubules and components of the Golgi apparatus,
which suggests that microtubules may be impor-
tant in the maintenance oftheGolgicomplex. The
fact that the administration of another antimicro-
tubule agent, vinblastine sulfate, leads to qualita-
tively similar changes lends support for this idea.
This point has also been made by Patzelt et al.
(10), using the parotid gland as a model.
Thechanges that occur in Golgi complexes after
colchicine (or vinblastine) treatment take several
forms. Clearly, dictyosome cisternal membranes
are reduced in number after treatment with anti-
microtubule agents. This observation has been
made previously for Golgi complexes of cultured
TABLE I
Effect of Colchicine on Content of Hepatocyte Organelles
' Figures in this column represent thenumbers of animals from whichtissue wasobtained formorphometric analysis
5 h after the administration of saline or colchicine.
$P < 0.01 as compared to values obtained after saline treatment.
§ P < 0.05 as compared to values obtained after saline treatment.
hepatocytes (3) and various other cell types (8, 9,
16). However, other components of Golgi com-
plexes seem not to be altered by antimicrotubule
agents and thus help in the identification of pre-
sumptive complexes. For example, altered Golgi
complexes still include clusters of coated and
smooth-surfaced vesicles in association with
VLDL-filled vacuoles. Variable numbers of vac-
uoles contain electron-dense material and resem-
ble lysosomes. In addition to these changes asso-
ciated with Golgi regions, otherchanges in VLDL
compartmentalization occur. Vacuoles containing
VLDL accumulate throughout the cytoplasm and
many reveal limiting membranes studded with
ribosomes. In cells of control animals, <5% of the
total VLDL found in cells are bounded by RER
membranes: aftercolchicine (0.7 mg/kg), not only
does the accumulated hepatocyte VLDL content
increase, but 25% of the VLDL are now within
rough-surfaced membranes.
Thus, as a result of treatment with antimicro-
tubule drugs, Golgi cisternal membranes disap-
pear, and, perhaps as a consequence, VLDL ac-
cumulate within both rough and smooth-surfaced
vacuoles. That the VLDL-filled vacuoles are not
efficiently discharged is suggested by these and
other (6, 17) studies of low VLDL-TG secretion
ratesaftercolchicine and/or vinblastine treatment.
That the excess VLDL may be degraded by cri-
nophagy is suggested by the increase of VLDL
within electron-dense bodies after treatment with
colchicine and/or vinblastine (see also references
6 and 17).
Themorphometric techniques used in this study
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Structures (volume density x 10')
Agent
mgtkg body wt
Animals' Golgi Lysosomes
VLDL
(Golgi)
VLDL
(lysosome)
VLDL
(endoplasmic
reticulum)
Saline 10 2.30 ± 0.71 0.74 ± 0.22 0.48 ± 0.14 0.06 ± 0.02 0.25 ± 0.06
Colchicine
0.3 5 2.08 ± 0.60 1 .88 ± 0.25$ 0.39±0.10 0.41±0.08$ 0.85±0.15§
0.5 5 1 .70 t 0.75
0.7 10 0.37 ± 0.11$ 1 .50 t 0.26§ 0.02 t 0.02$ 0.42 ± 0.08$ 1.67 t 0.20$
1 .0 5 0.39 ± 0.16§permit us to localize and quantify aggregated (as-
sembled) microtubule protein which is visible at
the electron microscope level. However, submi-
croscopic aggregated states of microtubule protein
may also exist in cells, and it is likely that anti-
microtubule agents would cause the disaggrega-
tion of protein in this state, as well as that of
visible microtubules. On the basisof this thinking
and the specific findings ofthis study, it is possible
to offer a working hypothesis to explain the role
of microtubules (assembled microtubule protein)
in hepatic VLDL secretion. Aggregated microtu-
bule protein is essential in maintaining the struc-
tural integrityofGolgi membranes and associated
structures. Antimicrotubule agents lead to a dis-
aggregation of microtubule protein, and asubstan-
tial number of Golgi complexes become disorga-
nized when the level of disaggregation reaches a
critical point. It is this disorganizationof the Golgi
complexes which results in the accumulation of
VLDL and impairment of VLDL secretion, pos-
sibly because the membranes of the formed
VLDL-containing vacuoles lack a critical compo-
nent for transport which is normally acquired in
passage through the Golgi complex. Finally, it is
the persistent association ofsome microtubule pro-
tein with Golgi complexes, and the resulting per-
sistence of a small number of intact Golgi com-
plexes, which permit the secretion of VLDL-TG
to continue at a markedly reduced level. Alterna-
tively, one couldpostulate that a minor portion of
newly synthesized VLDL is normally discharged
in a nonregulated (non-Golgi) pathway (4), and
that this pathway continues to function despite
treatment of animals with antimicrotubule agents.
Obviously, this hypothesis is speculative and
requires experimental verification. Alternative ex-
planations can be offered. For example, the lack
of parallelism between microtubule volume den-
sity and VLDL secretion at 0.3 mg/kg colchicine
could be interpreted to mean that no relationship
exists between microtubules and VLDL secretion.
Redman et al. (15), utilizing very high doses of
colchicine (100 mg/kg) and very short periods of
treatment (1 h) have, in fact, reported a dissocia-
tion between hepatocyte microtubule content and
albuminrelease (albumin presumably beingtrans-
ported by the same intracellular structures as
VLDL), and concluded that microtubules are not
directly associated with albumin transport. How-
ever, it must be mentioned that microtubules were
not measured in that study, and it is possible that
a quantitative relationship between total microtu-
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bule content and albumin secretion was missed.
Even so, parallel responses do not prove that two
events are related, and it is certainly possible that
colchicine has other effects which are responsible
for the observed disorganization of Golgi com-
plexes and/or the inhibition of VLDL secretion.
For example, colchicine has been shown to affect
nucleoside transport (7). Moreover, colchicine has
been shown to bind to (5, 18), and to affect the
mobility of, a variety of membrane components
(20, 21), and a direct (nonmicrotubule) effect on
Golgiand/or Golgi-derived membranes cannot be
discounted.
On the other hand, in a recent report, Caron
and Berlin (2) have shown that microtubule pro-
tein can be selectively adsorbed to artificial phos-
pholipid vesicles inducing stacking and/or fusion
of the liposomes into multilamellar structures. If
microtubule protein were bound to, and caused
the stacking of, cellular membranes in vivo (such
as Golgi cisternal membranes), one could imagine
that colchicine could dissociate this binding and
cause the type of structural change of the Golgi
complex described in this study.
In any event, the fact that a totally different
antimicrotubule agent, vinblastine sulfate, mimics
every aspect of the colchicine effect makes it dif-
ficult to ignore the idea that microtubules are
linked to secretory processes in the liver. For this
reason, our current hypothesis ties microtubules
(assembled microtubule protein) to the various
kinetic and morphological events observed after
colchicine treatment, and describes a permissive
action for microtubules in VLDL-TG secretion as
postulated in an earlier publication (14).
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